Sort by

Send to

Choose Destination

Search results

Items: 6


[Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain].

Ariza R, Van Walsem A, Canal C, Roldán C, Betegón L, Oyagüez I, Janssen K.

Farm Hosp. 2014 Jul 1;38(4):257-65. doi: 10.7399/fh.2014.38.4.1137. Spanish.


Hospitalizations due to severe hypoglycemia in patients with diabetes mellitus in Spain.

Lindner L, García-Sánchez R, Alvarez C, Betegón L, Badia X.

Rev Clin Esp (Barc). 2013 Nov;213(8):370-6. doi: 10.1016/j.rce.2013.02.015. Epub 2013 May 14. English, Spanish.


Model of excellence in Rheumatology Day Hospitals in Spain: the HD-Reumatolex project.

Román Ivorra JA, Sanmarti R, Collantes-Estévez E, Carreño Pérez L, Betegón L.

Reumatol Clin. 2013 May-Jun;9(3):142-7. doi: 10.1016/j.reuma.2012.07.001. Epub 2012 Oct 11. English, Spanish.


[Cost and cost-effectiveness analysis of the preferred treatment for initial antiretroviral therapy in HIV infected adults according to 2012 GESIDA/National AIDS Plan guidelines].

Betegón L, Cotarelo M, Vendrell B.

Enferm Infecc Microbiol Clin. 2012 Oct;30(8):508-9; author reply 511-2. doi: 10.1016/j.eimc.2012.06.002. Epub 2012 Jul 21. Spanish. No abstract available.


Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain.

Diez-Domingo J, Suriñach NL, Alcalde NM, Betegón L, Largeron N, Trichard M.

BMC Public Health. 2010 Aug 10;10:469. doi: 10.1186/1471-2458-10-469.


Using triple antiplatelet therapy in patients with non-ST elevation acute coronary syndrome managed invasively: a cost-effectiveness analysis.

Latour-Pérez J, de Miguel Balsa E, Betegón L, Badia X.

Value Health. 2008 Sep-Oct;11(5):853-61. doi: 10.1111/j.1524-4733.2008.00338.x. Epub 2008 May 16.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk